Effectiveness of a Lifestyle Intervention, for People With SMI Who Meet Metabolic Syndrome Criteria
Impact of a Physical Health Promotion Program for People With Serious Mental Illness
1 other identifier
interventional
61
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of a lifestyle intervention, to reduce the risk of metabolic syndrome in patients with serious mental illness who receive treatment with antipsychotic medications. The hypothesis of the study is that: the application of a physical health promotion program in people with serious mental illness, who receive treatment with antipsychotic medications, carried out by a mental health nurse, will decrease the presence of metabolic syndrome and contribute to improve their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 20, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2019
CompletedFebruary 28, 2019
September 1, 2017
12 months
September 20, 2017
February 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease of at least 3 of the 5 criteria of metabolic syndrome
Fasting glucose ≥110 mg/dL (or receiving drug therapy for hyperglycemia) Blood pressure ≥130/85 mm Hg (or receiving drug therapy for hypertension) Triglycerides ≥150 mg/dL (or receiving drug therapy for hypertriglyceridemia) HDL-C \<40 mg/dL in men or \<50 mg/dL in women (or receiving drug therapy for reduced HDL-C) Waist circumference ≥102 cm in men or ≥88 cm in women
6 months
Secondary Outcomes (4)
Metabolic syndrome prevalence
6 months
use of antipsychotic
6 months
Toxic habits
6 months
Quality of life improvement
6 months
Study Arms (2)
Experimental Group
EXPERIMENTALThis group will carry out the lifestyle intervention (Physical health promotion program) during 6 months. The group will attend a session per week.
Control group
NO INTERVENTIONusual care
Interventions
The program has 24 sessions. Each session has two parts: * first part: half an hour of theoretical content, about the Metabolic syndrome, the effect of unhealthy lifestyle, toxic habits such as smoking or drinking alcohol, dietary habits or physical activity. * Second part: 1 hour of physical activity (walk)
Eligibility Criteria
You may qualify if:
- Diagnostic of serious mental illness.
- Treatment with antipsychotics.
- Met at least 3 of the 5 criteria of metabolic syndrome According to the NCEP ATP III definition.
You may not qualify if:
- Medical contraindications to exercise
- Admitted to hospital.
- intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
university hospital Ramón y Cajal
Madrid, 28034, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2017
First Posted
September 25, 2017
Study Start
September 1, 2017
Primary Completion
August 31, 2018
Study Completion
February 2, 2019
Last Updated
February 28, 2019
Record last verified: 2017-09